Which neurotransmitter is least likely to be targeted by antidepressant medications?

Prepare for the KMK Live Session General Pharmacy Test. Use flashcards and multiple-choice questions with hints and explanations for each question. Get ready for your exam with confidence!

Multiple Choice

Which neurotransmitter is least likely to be targeted by antidepressant medications?

Explanation:
Antidepressants mainly work by boosting monoamine signaling involved in mood, especially serotonin and norepinephrine, with some agents also affecting dopamine. Serotonin reuptake inhibitors increase serotonin levels in the synapse, SNRIs raise both serotonin and norepinephrine, and certain drugs influence dopamine pathways. Acetylcholine isn’t a primary target for treating depression; while anticholinergic effects can appear with some antidepressants, they reflect side effects rather than the therapeutic mechanism. So acetylcholine is the least likely neurotransmitter to be directly targeted by antidepressant medications.

Antidepressants mainly work by boosting monoamine signaling involved in mood, especially serotonin and norepinephrine, with some agents also affecting dopamine. Serotonin reuptake inhibitors increase serotonin levels in the synapse, SNRIs raise both serotonin and norepinephrine, and certain drugs influence dopamine pathways. Acetylcholine isn’t a primary target for treating depression; while anticholinergic effects can appear with some antidepressants, they reflect side effects rather than the therapeutic mechanism. So acetylcholine is the least likely neurotransmitter to be directly targeted by antidepressant medications.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy